Literature DB >> 2415311

Phorbol ester enhances deoxynucleoside incorporation while inhibiting proliferation of K-562 cells.

O R Colamonici, J B Trepel, L M Neckers.   

Abstract

Recently a new technique has been developed to study bromodeoxyuridine incorporation into DNA as a function of the cell cycle phase distribution. We have made the observation that treatment of the hematopoietic cell line K-562 results in a complete and immediate cessation of cell growth, although tritiated thymidine incorporation is markedly elevated for as long as 5 days. We have made use of that newly described technique to study this phenomenon.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2415311     DOI: 10.1002/cyto.990060614

Source DB:  PubMed          Journal:  Cytometry        ISSN: 0196-4763


  5 in total

1.  Phorbol ester induces c-sis gene transcription in stem cell line K-562.

Authors:  O R Colamonici; J B Trepel; C A Vidal; L M Neckers
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  DNA cell cycle studies in uveal melanoma.

Authors:  D H Char
Journal:  Trans Am Ophthalmol Soc       Date:  1988

3.  Ras-mediated cell cycle arrest is altered by nuclear oncogenes to induce Schwann cell transformation.

Authors:  A J Ridley; H F Paterson; M Noble; H Land
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

4.  MR-1 blocks the megakaryocytic differentiation and transition of CML from chronic phase to blast crisis through MEK dephosphorylation.

Authors:  W Zhao; H He; K Ren; B Li; H Zhang; Y Lin; R-G Shao
Journal:  Blood Cancer J       Date:  2013-03-29       Impact factor: 11.037

5.  Megakaryocytic differentiation in human chronic myelogenous leukemia K562 cells induced by ionizing radiation in combination with phorbol 12-myristate 13-acetate.

Authors:  Katsumi Hirose; Satoru Monzen; Haruka Sato; Mariko Sato; Masahiko Aoki; Yoshiomi Hatayama; Hideo Kawaguchi; Yuichiro Narita; Yoshihiro Takai; Ikuo Kashiwakura
Journal:  J Radiat Res       Date:  2012-12-21       Impact factor: 2.724

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.